In this study, 2-formylpyridine thiosemicarbazones and three different heterocyclic pharmacophores were combined to prepare thiosemicarbazone-piperazine mPip-FTSC (HL 1 ) and mPip-dm-FTSC (HL 2 ), thiosemicarbazone-morpholine Morph-FTSC (HL
Introduction
Thiosemicarbazones (TSCs) are known as potent metal chelators with high affinity for first row transition metals. 1, 2 TSCs and their metal complexes possess a variety of biological activities, such as antifungal, antiviral, antibacterial, antimalarial and anticancer. [3] [4] [5] [6] [7] [8] The anticancer activity of α-N-heterocyclic TSCs (HCTs) has been known since the 1950s when 2-formylpyridine thiosemicarbazone (FTSC) showed antileukemic activity in a mice model. 9 To date, the best-studied HCT is 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP or Triapine). Several clinical phase I and II trials revealed that Triapine is ineffective against a variety of solid tumors but very promising against hematologic malignancies such as leukemia. [10] [11] [12] [13] [14] [15] [16] [17] [18] The outcome of a recent clinical phase II study including 37 patients with aggressive myeloproliferative neoplasms, with a response rate of 49% and complete remission in 24% of all patients, has recently been reported. 19 Ribonucleotide reductase (RNR), 20, 21 an enzyme catalyzing the reduction of ribonucleotides to the corresponding 2′-deoxyribonucleotides, which is the rate determining step in DNA synthesis, 22 and topoisomerase IIα (Topo IIα), an enzyme that controls the DNA topology during cell division by introducing temporary double strand breaks have been considered as possible targets for this class of compounds. [23] [24] [25] [26] New insights into the mechanism of action for RNR inhibiting HCTs and especially Triapine were recently reported. [27] [28] [29] [30] The enzymes ATP binding pocket was suggested as major target for Topo IIα inhibiting HCTs. 31 The reaction of copper(II) with HCTs leading to square-planar complexes markedly enhances the Topo IIα inhibition rate. 32 2-Acetylpyridine thiosemicarbazones possess very high cytotoxicity in human cancer cell lines with IC 50 values in the nanomolar concentration range and the ability to destroy the tyrosyl radical of the mammalian RNR R2 protein under the slightly reducing conditions typical for tumors. 33, 34 However, high general toxicity and, consequently, the low therapeutic index along with low aqueous solubility for these and other related thiosemicarbazones prompted us to design hybrid systems, based on thiosemicarbazones and other pharmacophores. Recently, we prepared proline-TSC hybrids (3-methyl-(S)-pyrrolidine-2-carboxylate-2-formylpyridine thiosemicarbazone (L-Pro-FTSC) and 3-methyl-(R)-pyrrolidine-2-carboxylate-2-formylpyridine thiosemicarbazone (D-Pro-FTSC)) and their copper(II) complexes. 35 These new compounds are highly water soluble but exhibit very low cytotoxicity, most probably because of their very low lipophilicity. We decided to extend our work and use other pharmacophoric groups for attachment at the 6-position of the TSCs pyridine ring, in order to increase the lipophilicity and modulate the antiproliferative activity. We attached the six-membered rings methylpiperazine and morpholine as well as methylpyrrole-2-carboxylate containing a five-membered planar heterocycle. It is well-known that the attachment of a piperazine moiety on a hydrophobic scaffold has a favourable effect on its water solubility, [36] [37] [38] [39] moreover the piperazine heterocycle is found in a broad variety of biologically active compounds, some of which are currently used in clinical therapy. [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] Biologically active metal-based compounds containing a piperazine ring have also been reported. [50] [51] [52] [53] [54] Morpholine is another well-known water-solubilizing unit incorporated in structures of biologically active compounds, showing often favorable pharmacologic effects. [55] [56] [57] In particular, a morpholine moiety is also present in the approved anticancer drugs Gefitinib (against certain breast, lung and other cancers) and Carfilzomib (against multiple myeloma). 58, 59 A series of TSCs with different substituents at position 4 of the pyridine ring was tested on mice bearing sarcoma 180 ascites cells. Intriguingly, the 4-morpholino-2-formylpyridine thiosemicarbazone was the most effective compound, increasing the average survival time of tumor bearing mice from 13.8 to 38 days. 60 The methylpyrrole-2-carboxylate ring was chosen as third possible option since it resembles proline. Herein, we report the synthesis of six new organic compounds, namely HL [1] [2] [3] [4] [5] [6] , representing three types of potential hybrid ligands for transition metals, as well as six copper(II) complexes all shown in Chart 1. The compounds were charac-
Synthesis of ligands
1-((6-(Dimethoxymethyl )pyridin-2-yl)methyl )-4-methylpiperazine. 2-(Chloromethyl)-6-(dimethoxymethyl)pyridine (1.82 g, 9.02 mmol) was dissolved in a 1 : 1 mixture of dry THF and dry dichloromethane (40 mL) in a 100 mL Schlenk tube. Methylpiperazine (1.50 mL, 13.53 mmol) and triethylamine (3.64 mL, 27.06 mmol) were added. The reaction mixture was stirred at 46°C overnight. The next day a white precipitate of triethylammonium chloride was filtered off and washed with THF. The filtrate was concentrated under reduced pressure to yield a brown oily raw product. This was purified on a silica column using chloroform/methanol 4 : 1 as eluent. The solvent was removed under reduced pressure to yield the product as a yellow oil. Yield: 1.99 g, 79%.
1 H NMR (500 MHz, DMSO-d 6 3(Pip) ). 4-((6-(Dimethoxymethyl)pyridin-2-yl)methyl)morpholine. To 2-(Chloromethyl)-6-(dimethoxymethyl)pyridine (0.80 g, 3.97 mmol) in a 1 : 1 mixture of dry THF and dry dichloromethane (20 mL) in a 50 mL Schlenk tube were added morpholine (0.52 mL, 5.96 mmol) and triethylamine (1.60 mL, 11.91 mmol). The reaction mixture was stirred at 46°C overnight. The next day a white precipitate of triethylammonium chloride was filtered off and washed with THF. The filtrate was concentrated under reduced pressure to yield a brown oily raw product. This was purified on a silica column using chloroform/methanol 97.5 : 2.5 as eluent. The solvent was removed under reduced pressure to yield the product as a yellow oil. Yield: 0.93 g, 93%. 1 H NMR (500 MHz, DMSO-d 6 ) δ 7.82 (t, J = 7.7 Hz, 1H, CH (Ar) ) .
Methyl 1-((6-(dimethoxymethyl)pyridin-2-yl)methyl)-1H-pyrrole-2-carboxylate. Sodium hydride (60 wt% dispersion in mineral oil) (0.10 g, 2.48 mmol) was suspended in dry DMF (3 mL) in a 25 mL Schlenk tube and cooled to 0°C. A solution of methylpyrrole-2-carboxylate (0.31 g, 2.48 mmol) in dry DMF (4.5 mL) was added dropwise. Then a solution of 2-(chloromethyl)-6-(dimethoxymethyl)pyridine (0.50 g, 2.48 mmol) in dry DMF (2.5 mL) was added slowly. The reaction mixture was allowed to reach room temperature and then stirred overnight. The next day the crude mixture was poured into ice water (about 100 mL) and extracted with ethyl acetate (3 × 50 mL). The combined organic phases were dried over magnesium sulfate and the solvent was removed under reduced pressure to give a yellow, oily raw product. This was purified on a silica column using a mixture of 1 : 2 ethyl acetate/hexane as eluent. The product was obtained after removal of the solvent as a colorless oil. Yield: 0.42 g, 58%. 1 6-((4-Methylpiperazin-1-yl)methyl)picolinaldehyde. A solution of 1-((6-(dimethoxymethyl)pyridin-2-yl)methyl)-4-methylpiperazine (0.93 g, 3.50 mmol) in water (35 mL) and 12 M HCl (0.91 mL, 10.92 mmol) in a 100 mL round-bottom flask was stirred at 60°C overnight. The next day the reaction mixture was combined with a saturated aqueous solution of sodium bicarbonate (about 100 mL) and extracted with dichloromethane (3 × 40 mL). The united organic phases were dried over magnesium sulfate and the solvent was removed under reduced pressure. The product was obtained as a yellow oil. Yield: 0.51 g, 67%. 1 3(Pip) ). 6-(Morpholinomethyl)picolinaldehyde. 4-((6-(Dimethoxymethyl)pyridin-2-yl)methyl) morpholine (0.92 g, 3.65 mmol) was mixed with water (35 mL) and 12 M HCl (0.95 mL, 11.40 mmol) in a 100 mL round-bottom flask. The reaction mixture was stirred at 60°C overnight. The next day the reaction mixture was combined with a saturated aqueous of sodium bicarbonate (about 100 mL) and extracted with dichloromethane (3 × 40 mL). The united organic phases were dried over magnesium sulfate and the solvent was removed under reduced pressure. The product was obtained as a yellow oil. Yield: 0.62 g, 82%.
1 H NMR (500 MHz, DMSO-d 6 ) δ 9.98 
pH-Potentiometric measurements
The purity and aqueous phase stability of the ligands mPipdm-FTSC (HL 2 ) and Morph-dm-FTSC (HL 4 ) were verified and the exact concentrations of the stock solutions prepared were determined by the Gran method. 63 The pH-metric measurements for determination of the protonation constants of the ligands and the overall stability constants of the copper(II) complexes were carried out at 298.0 ± 0.1 K in water and at an ionic strength of 0.10 M (KCl) in order to keep the activity coefficients constant. 64 The average water ionization constant pK w , is 13.76 ± 0.01, which corresponds well to the literature data. 65 The reproducibility of the titration points included in the calculations was within 0.005 pH. The pH-metric titrations were performed in the pH range 2.0-11.5. The initial volume of the samples was 5.0 mL. The concentration of the ligands was 2 mM and metal ion-to-ligand ratios of 1 : 1, 1 : 1.5, 1 : 2 and 1 : 3 were used. The accepted fitting of the titration curves was always less than 0.01 mL. Samples were deoxygenated by bubbling purified argon through them for ca. 10 min prior to the measurements and argon was also passed over the solutions during the titrations. The protonation constants of the ligands were determined with the computer program HYPERQUAD. 66 PSEQUAD 67 was utilized to establish the stoichiometry of the complexes and to calculate the stability constants
r , where M denotes the metal ion (copper(II)) and L the completely deprotonated ligand. In all calculations exclusively titration data were used from experiments, in which no precipitate was visible in the reaction mixture.
UV-vis spectrophotometric, spectrofluorimetric and 1 H NMR measurements A Thermo Scientific Evolution 220 spectrophotometer was used to record the UV-vis spectra in the 200 to 1050 nm window. The path length was 1 or 0.5 cm. Stability constants and the individual spectra of the complexes were calculated by the computer program PSEQUAD. 67 The spectrophotometric titrations were performed on samples of the copper(II) complexes 2 and 4 of ligands mPip-dm-FTSC (HL 2 ) and Morph-dm-FTSC (HL 4 ) over the pH range between 2 and 11.5 at an ionic strength of 0.10 M (KCl) in water at 298.0 ± 0.1 K. The concentration of the metal complexes was 2.5 mM. Measurements on the copper(II) complexes 2 and 4 were also carried out by preparing individual samples, in which the 0. (1-5) were determined by the traditional shake-flask method in n-octanol/buffered aqueous solution at pH 7.4 at 298.0 ± 0.2 K as described previously. 68, 69 Two parallel experiments were performed for each sample. The ligands and the complexes were dissolved at 100 μM (∼30 μM in the case of HL 5 and its complex 5) in the n-octanol pre-saturated aqueous solution of the buffer (10 mM HEPES) at constant ionic strength (0.10 M KCl). The aqueous solutions and n-octanol with 1 : 1 phase ratio were gently mixed with 360°vertical rotation for 3 h to avoid the emulsion formation, and the mixtures were centrifuged at 5000 rpm for 5 min by a temperature controlled centrifuge (Sanyo) at 298 K. After separation UV-vis spectra of the ligands or complexes in the aqueous phase were compared to those of the original aqueous solutions. Since measurable amounts of the ligand HL 5 and its copper(II) complex 5 were not found in the aqueous phase after partitioning, their log D 7.4 values were merely estimated.
EPR measurements and deconvolution of the spectra
All continuous wave (CW)-EPR spectra were recorded with a BRUKER EleXsys E500 spectrometer (microwave frequency 9.85 GHz, microwave power 10 mW, modulation amplitude 5 G, modulation frequency 100 kHz). The pH-dependent series of isotropic EPR spectra were recorded in a circulating system, at room temperature. A Heidolph Pumpdrive 5101 peristaltic pump was used to transport the solution from the titration pot through a capillary tube into a Bruker flat cell placed in the cavity of the instrument. The EPR titrations were performed over the pH range between 1.5 and 12.0 at an ionic strength of 0.10 M (KCl) under nitrogen atmosphere. Samples contained 1 mM mPip-dm-FTSC (HL 2 ) or Morph-dm-FTSC (HL 4 ) and 1 mM or 0.5 mM copper(II) ions. A 0.1 M KOH solution was added to the samples to adjust the pH, which was measured with an Orion 710A pH-meter equipped with a Metrohm 6.0234.100 glass electrode. For selected pH values (where predominantly complexes formed) 0.1 mL samples were introduced into quartz EPR tubes and measured individually at 77 K. Before the simulation, the measured spectra were corrected by subtracting the spectra of water measured in the same circulating system. A phase correction of −7 degree for the series of Morph-dm-FTSC (HL 4 ) and −8 degree for the mPip-dm-FTSC (HL 2 ) containing samples was used to correct the phase of the spectra which were probably shifted due to the not perfectly perpendicular position of the flat cell to the magnetic field. Both series of the pH-dependent isotropic CW-EPR spectra were simulated by the "two-dimensional" method using the 2D_EPR program. 70 The parameters g o , A where M I denotes the magnetic quantum number of the paramagnetic metal ions. The equilibrium concentrations of the copper(II) complexes were varied by fitting their overall stability constants β(M p L q H r ) defined in the section of pH-potentiometric measurements. For each spectrum, the noise-corrected regression parameter (R j for the j th spectrum) is derived from the average square deviation (SQD) between the experimental and the calculated intensities. For the series of spectra, the fit is characterized by the overall regression coefficient R, calculated from the overall average SQD. The overall regression coefficient was 0.9933 for the series of Morph-dm-FTSC and 0.9928 for the series of mPip-dm-FTSC. The details of the statistical analysis were published previously. 70 The anisotropic EPR spectra, recorded at 77 K, were analyzed individually with the aid of the EPR program. 71 In case of copper(II) complexes, the anisotropic EPR parameters: rhombic g-tensor (g x , g y , g z ), rhombic copper(II) hyperfine tensor (A and z denotes the directions of the g-tensor) were fitted. For the description of the linewidth the orientation dependent α, β and γ parameters were used to set up each component spectra. Since a natural CuCl 2 salt was used for the measurements, both the isotropic and anisotropic spectra were calculated as the sum of the spectra of 63 Cu and 65 Cu weighted by their natural abundances. The hyperfine and superhyperfine coupling constants and the relaxation parameters were obtained in field units (Gauss = 10 −4 T).
Crystallographic structure determination 72 Crystal data, data collection parameters, and structure refinement details are given in Table 1 . The structures were solved by direct methods and refined by full-matrix least-squares techniques. Non-H atoms were refined with anisotropic displacement parameters. H atoms were inserted in calculated positions and refined with a riding model. In the crystal structure of 1·0.15CH 3 OH a partly occupied (15%) co-crystallized methanol molecule position was found, while in the crystal structure of 3·0.5(C 2 H 5 ) 2 O half 
, where n is the number of reflections and p is the total number of parameters refined. 
MTT assay
Antiproliferative activity of the investigated ligands and complexes was determined using 3-(4,5-dimethyl-2-thiazolyl)-2,5-2H-diphenyltetrazolium bromide (MTT, Sigma-Aldrich) assay. 75 Cells were seeded into 96-well cell culture plates (Thermo Scientific Nunc™), at a cell density of 4000 cells per well (HeLa), 6000 cells per well (A549), 5000 cells per well (MRC-5) and 7000 cells per well (LS174) in 100 µL of culture medium. After 24 h of growth, cells were exposed to the serial dilutions of the tested compounds. The investigated compounds were dissolved in sterile water at a concentration of 10 mM as stock solution (complexes 2 and 4), 5 mM (complex 1), or 2 mM (complex 3), and prior the use diluted with nutrient medium to the desired final concentrations (in range up to 300 µM 50 value, defined as the concentration of the compound causing 50% cell growth inhibition, was estimated from the dose-response curve.
Results and discussion
These studies examined the effects of attachment of methylpiperazine, morpholine and methylpyrrole-2-carboxylate to the pyridine ring of the parent thiosemicarbazone on the aqueous solubility, lipophilicity, ability to form copper(II) complexes, their thermodynamic stability in aqueous solution, and antiproliferative activity in human cancer cell lines HeLa, A549 and LS174, as well as in nontumorigenic cell line MRC5.
Synthesis and characterization of HL 1 -HL
6
The organic hybrids were synthesized in six steps, as shown in Scheme S2. † The first four steps were described in detail previously. 61, 76 The key aldehydes were prepared in two steps.
First, 2-(chloromethyl)-6-(dimethoxymethyl)pyridine (D) was allowed to react with methylpiperazine or morpholine in THF in the presence of triethylamine or with methylpyrrole-2-carboxylate in DMF in the presence of NaH, following a literature procedure, 77 affording compounds E-G in 79, 93 and 58% ring from planarity is at −28.1(3) and −28.3(3)°in 1 and 3, and at −29.62 (19) and −22.5(3)°in 2 and 4 (for one of the two crystallographically independent molecules), respectively. This is not surprising if one takes into account the presence of an aliphatic carbon atom (C8/C10) in this chelate ring.
The terminal amine nitrogen N4 of the thiosemicarbazone moiety is involved as a proton donor in hydrogen bonding to the nitrogen atom N3 i of a neighboring molecule of 1 forming pairs of molecules as displayed in Fig. S1 † and in hydrogen bonding to Cl1 ii , where i and ii denote the atoms generated by symmetry transformations −x + 2, −y + 1, −z + 1 and x + 1, y, z, respectively. The protonated atom N6 acts as a proton donor to the chloride counterion with N6⋯Cl2 i at 3.0837 (14) 10.29). 81 Taking into account these data we attributed the pK 2 of Morph-dm-FTSC to the deprotonation of the morpholinium ion. It should also be noted that the assignment of the pK a values for the methylpiperazine-thiosemicarbazone hybrid is not so straightforward. The proton dissociation steps of the ligands studied were assigned to the different functional (17), Cu1a-S1a 2.2523(6), Cu1a-N5a 2.1406(17), Cu1a-Cl1a 2.5088(6), N2a-N3a 1.358(2), C7a-S1a 1.754(2), N1a-Cu1a-N2a 79.68 (7), N1a-Cu1a-N5a 79.90 (7), N2a-Cu1a-S1a 83.88 (5), N5a-Cu1a-S1a 111.88 (5) (Fig. 7) revealed that most of the proton resonances are fairly sensitive to stepwise proton dissociation processes. In addition, the presence of Z and E isomers was observed. These were found to be involved in slow interconversion processes with regard to the NMR time scale (t 1/2 (obs) > ∼1 ms) in a wide pH-range. Their proton resonances were well-separated in most of the cases. However, the lines tend to broaden at pH < ∼4 due to faster isomerization around the CH 12 vN 1 double
bond. Integrated signals of the different ligand protons belonging to the E and Z isomers were converted to molar fractions showing the predominant formation of the E isomer in the whole pH range, although the ratio of the isomers is undoubtedly changing due to the deprotonation steps (Fig. 6A) . The E isomer was also found to be the major species in DMSO-d 6 and its molar fraction (0.62) corresponds well to that found for aqueous solution (0.61) between pH ∼7 and ∼9, where the neutral HL form predominates. Based on the pHdependence of the 1 H NMR signals (Fig. S2 †) microscopic proton dissociation constants could be computed for both Z a Estimated from the summed concentration distribution curves of the E/Z isomers in Fig. 6B and S4B.
Scheme 1 Deprotonation steps of the H 3 L 2+ form of ligand Morph-dm-FTSC (HL 4 ) for its E (A) and Z (B) isomers. and E isomers ( Table 2 ). Concentration distribution curves were calculated based on these data providing the macroscopic constants as well (Table 2) , which are in good agreement with the results of the pH-potentiometry. The first deprotonation process was accompanied by significant changes of the chemical shifts of the C 6 H pyridine ring proton and C 14,15 H 3 terminal methyl protons. The morpholine (C 8,11 H 2 , C 9,10 H 2 ) and hydrazinic H functional groups of both isomers of Morph-dm-FTSC as indicated in Scheme 1. On the other hand, marked differences are found between the pK a values of the Z and E isomers ( Table 2) . Most probably the hydrogen bond between the pyridyl nitrogen and the N 2 hydrazinic H moiety in the H 2 L + , HL forms of the Z isomer is responsible for these differences. Namely, it decreases pK 1 of the Z isomer via stabilization of the conjugate base (H 2 L + ) as well as pK 2 due to the diminished π-electron density in the pyridine ring, which results in an easier deprotonation of the N 5 morpholinium H + group. The pK 3 of the Z isomer is higher than that of the E form, since the dissociation of the N 2 hydrazinic H functional group participating in the hydrogen bonding is more difficult. The pH-dependent 1 H NMR spectra of mPip-dm-FTSC (Fig. S3 †) and the changes of the chemical shifts of the various protons (Fig. S4 †) were analyzed similarly. Data revealed that pK 1 corresponds to the deprotonation of pyridinium nitrogen. However only the macroscopic constant could be determined by pH-potentiometry (Table 2) . At the same time the isomerization has no effect on the pK 3 value since the N 6 piperazinium H + group is quite far from the CH 12 vN 1 double bond. The E isomer was found to be predominant in the whole pH range studied (Fig. S5 †) . It is worth noting that the pK a values of the N pyridyl H + functional group of the studied thiosemicarbazone-based hybrids are significantly lower compared to those of ligands PTSC, APTSC 81 due to the electron withdrawing effect of the charged morpholinium and methylpiperazinium moieties. Both ligands mPip-dm-FTSC (HL 2 ) and Morph-dm-FTSC (HL 4 ) possess intrinsic fluorescence. 3-Dimensional fluorescence spectra recorded in aqueous solution at pH 7.4 ( Fig. S6 †) reveal their fairly similar excitation (330 nm) and emission maxima (420 nm), although the emission intensity of the morpholine-thiosemicarbazone hybrid is by a factor of 3 higher in comparison to that of HL 2 .
The lipo-hydrophilic character of the ligands HL 1 -HL 5 was studied at pH 7.4 via the partitioning between n-octanol and water. The log D 7.4 values determined by the analysis of the UV-vis spectra of the aqueous phases before and after separation are listed in is much more lipophilic than the other ligands studied and its high log D 7.4 value is manifested in a strongly reduced aqueous solubility compared to that of the corresponding proline-thiosemicarbazone conjugates (L-and D-Pro-FTSC: log D 7.4 < −1.7). 35 It should be also noted that all the ligands studied except mPyrr-FTSC (HL 5 ) are more hydrophilic than Triapine (log D 7.4 = +0.85) 69 at physiological pH.
Solution chemistry: complex formation equilibria of copper(II) with ligands HL 2 and HL 4 and lipophilicity of the complexes
The main aim of the studies on complexation reactions of ligands mPip-dm-FTSC (HL 2 ) and Morph-dm-FTSC (HL 4 ) with copper(II) was monitoring the stability of the complexes 2 and 4 in aqueous solution especially at physiological pH. The complex formation processes were investigated by the combined use of pH-potentiometric, UV-vis and EPR titrations. The stoichiometries and cumulative stability constants of the complexes furnishing the best fits to the experimental data are listed in Table 4 . EPR spectra were recorded at various pH values at 1 : 1 and 1 : 2 metal-to-ligand ratios at room temperature and at 77 K; the fitted experimental and simulated isotropic spectra are depicted in Fig. 8A , B and S7A, B. † The simulation of the EPR spectra resulted in the individual isotropic and anisotropic EPR spectra and parameters of the various species (Fig. 8C , S7C and S8; † Table 5 ). The EPR measurements at both temperatures revealed the predominant formation of mononuclear mono-ligand complexes in different protonation states. The proton displacement by the metal ion due to complex formation is almost complete already at the starting pH value of the pH-potentiometric titrations ( pH ∼ 2) and a negligible amount of free copper(II) was detected by EPR at this pH, indicating the prominently high stability of the complexes formed with both ligands. complex by the ligands were followed by UV-vis spectrophotometry at pH 7.4 and 5.6, in the case of mPip-dm-FTSC (Fig. S9 †) and Morph-dm-FTSC, respectively. Absorbance values recorded at λ > 415 nm were used for calculations of the conditional stability constants (log β′) of [CuL] + , the only species contributing to the measured absorbance. The cumulative stability constants (log β) of [CuL] + were computed (Table 4) taking into account the protonation of the ligands at these pH values, which were kept constant during subsequent data evaluation.
In the case of Morph-dm-FTSC, [CuL] + predominates between pH ∼4 and ∼10. This is clearly indicated by the unaltered UV-vis spectra in the wavelength range of both the d-d (Fig. 9) and CT (Fig. S10B †) bands. EPR spectra were also intact in this particular pH range (Fig. S7A †) These results strongly indicate that the process is assigned to the deprotonation of the N 6 of the methylpiperazine moiety which is not involved in the binding to copper(II). The observed UV-vis spectral changes (Fig. S10A †) and EPR parameters ( Table 5 ) are in relatively good agreement with the corresponding values measured in solution, indicating that the coordination modes adopted by the ligands in solution are preserved upon freezing.
Representative concentration distribution curves were calculated by using the overall stability constants (average values obtained by the 3 methods) for the copper(II)-mPip-dm-FTSC (HL 2 ) and copper(II)-Morph-dm-FTSC (HL 4 ) systems at 1 : 1 metal-to-ligand ratio to represent the complex formation processes in the pH range studied (Fig. 10) . It can be con- Log D 7.4 values were determined for the copper(II) complexes 1-5 and are collected in Table 3 in order to characterize the hydro-lipophilic character of these species. Comparing these values to those of the metal-free ligands it can be concluded that the same lipophilicity trend is obtained. Namely, the terminal dimethylation results in somewhat increased values and complexes of the morpholine-thiosemicarbazone derivatives possess enhanced lipophilic character. Note that the copper(II) complexes are much more hydrophilic than the corresponding ligands since the positively charged [CuL] + species predominate at physiological pH. Complex 5 is much more lipophilic than the other complexes, although its log D 7.4 value cannot be determined exactly and compared to that of mPyrr-FTSC (HL 5 ).
Cytotoxicity in cancer cell lines
The antiproliferative activity of the ligands HL 1 -HL 4 and the copper(II) complexes 1-4 was evaluated for 48 h of continuous drug action, using colorimetric MTT assay. The study was performed in three human neoplastic cell lines, namely HeLa (cervical carcinoma), A549 (alveolar basal adenocarcinoma) and LS174 (colon carcinoma), and one human foetal lung fibroblast cell line (MRC-5), which was used as a noncancerous model for the in vitro cytotoxicity evaluation. The results for the ligands and their copper(II) complexes are summarized in Table 6 in terms of IC 50 values with their standard deviations.
The results revealed that compounds 1-4 exhibited significant antiproliferative activity (IC 50 < 100 μM) against all cell lines used, with complex 4 showing the highest cytotoxic potential. The most sensitive to the investigated compounds was proved to be the cell line LS174, as indicated by the calculated IC 50 values varying from 13.1 to 17.5 µM. In contrast, the ligands showed significantly lower activity than the parent 2-formyland/or 2-acetylpyridine thiosemicarbazones, except ligand HL 4 , which exhibited significant cytotoxic activity against both the MRC5 and LS174 cell lines (63.2 ± 4.2 and 15.9 ± 0.6 µM, respectively). The metal-free 2-formylpyridine thiosemicarbazone (FTSC) showed high cytotoxicity against human cancer cell lines 41M (ovarian carcinoma), SK-BR-3 (mammary carcinoma), SW480 (colon carcinoma) and HL60 (leukemia) after 96 or 72 h treatment with IC 50 values of 2.9 ± 0.6, 3.2 ± 0.6, 10.6 ± 0.1 and 3.3 ± 0.5 µM, respectively. 83, 84 The effect of substitution of azomethine hydrogen atom by a methyl group is cell line dependent. While there was no change in antiproliferative activity for 2-acetylpyridine thiosemicarbazone (APTSC) in the first two cancer cell lines, a considerable increase was observed against the other two cell lines (IC 50 = 0.4 ± 0.01 and 0.2 ± 0.02 µM).
Terminal N 4 -dimethylation of FTSC resulted in a very strong enhancement of antiproliferative activity reaching IC 50 values of 0.0040 ± 0.0009 and 0.0098 ± 0.0011 µM in 41M and SK-BR-3 cells after exposure for 96 h. 83 The favorable effect of N 4 -dimethylation is also well-documented for other related α-heterocyclic thiosemicarbazones. 31 The coordination of FTSC to copper(II) was reported to increase or decrease the activity depending on the cell type. [85] [86] [87] [88] In particular, [Cu-(FTSC)Cl 2 ] revealed an increase of cytotoxicity by a factor of 3 in SW480 cells when compared to that of FTSC, while against HL60 cells the activity of FTSC and the copper(II) complex was very similar. 84 The proline-FTSC hybrids, we synthesized previously, 80 showed a different activity compared to the compounds reported herein. Hybrids that were not methylated at the general trend observed in the literature. 31, 83 In contrast, the effect is opposite, although also cell type dependent, if the activity of compounds 1 and 2 is compared. The observed divergent effects of terminal N 4 -dimethylation suggest that structural modifications at the pyridine ring (coupling to piperazine and morpholine moieties which increases the denticity of the ligands) play an important role in structureactivity relationships.
Conclusions
The synthesis of new hybrid species as potential ligands for transition metals permitted the study of the effects of the methylpiperazine, morpholine and methylpyrrole-2-carboxylate attachment to the parent 2-formylpyridine thiosemicarbazone on the aqueous solubility, lipophilicity, ability to form copper(II) complexes, their thermodynamic stability and antiproliferative activity in human cancer cell lines HeLa, A549 and LS174, as well as in nontumorigenic cell line MRC5. The hybrid species HL 5 and HL 6 proved to be almost insoluble in water precluding any biological investigations. Attempts to hydrolyze the ester group to -COOH in these two compounds in order to improve the aqueous solubility and ascertain the biological potency of new compounds are undergoing in our laboratory. In contrast, the hybrids HL 1 -HL 4 possess excellent water solubility. The solution speciation of copper(II) complexes of HL 2 and HL 4 has been characterized in pure aqueous solution via a combined approach using pH-potentiometry, EPR spectroscopy und UV-vis spectrophotometry. 50 values in the nanomolar concentration range and are characterized by very high general toxicity, and, as a consequence have a low therapeutic index. Further experimental work to get insight into the mechanism of action of the prepared copper(II) complexes with hybrid ligands is required to ascertain whether they are really good candidates for further development as potential anticancer drugs.
